X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
IPCA Labs Fact Sheet, IPCA Labs Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA Labs Fact Sheet   (IPLB)

Here is the latest financial fact sheet of IPCA Labs. For more details, see the IPCA Labs quarterly results and IPCA Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.

IPCA LABS Price History

Price Rs 920.0
Mkt Cap Rs m 116,103
Vol '000 23.7
P/E X 29.3
P/CF X 27.8
EPS (TTM) Rs 31.4
% ch % 3.3
No. of shares m 126.20
% ch week % -0.4
% ch 1-mth % 14.9
% ch 12-mth % 39.8
52 week H/L Rs 940.8/590.1
(As on Mar 19, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

IPCA LABS Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
IPCA LABS EQUITY SHARE DATA
High Rs907899888643695 
Low Rs541591629503400 
Sales per share (Unadj.) Rs260.0249.2230.3254.5260.2 
Earnings per share (Unadj.) Rs37.920.17.615.419.0 
Diluted earnings per shareRs37.920.17.615.419.0 
Cash flow per share (Unadj.) Rs46.134.420.629.133.1 
Dividends per share (Unadj.) Rs5.001.0001.001.00 
Adj. dividends per shareRs5.001.000.001.001.00 
Dividend yield (eoy) %0.70.100.20.2 
Book value per share (Unadj.) Rs155.3174.1179.0194.6213.0 
Adj. book value per shareRs155.3174.1179.0194.6213.0 
Shares outstanding (eoy) m126.20126.20126.20126.20126.20 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x2.83.03.32.32.1 
Avg P/E ratio x19.137.099.537.228.9 
P/CF ratio (eoy) x15.721.736.919.716.6 
Price / Book Value ratio x4.74.34.22.92.6 
Dividend payout %13.25.006.55.3 
Avg Mkt Cap Rs m91,35694,05795,72372,30069,120 
No. of employees `00011.713.013.113.313.3 
Total wages/salary Rs m4,9805,6516,2566,9607,359 
Avg. sales/employee Rs Th2,798.52,416.42,213.32,414.62,477.4 
Avg. wages/employee Rs Th424.7434.3476.4523.2555.2 
Avg. net profit/employee Rs Th408.1195.473.3146.2180.6 
IPCA LABS INCOME DATA
Net Sales Rs m32,81831,44429,06532,12232,836 
Other income Rs m223327222210418 
Total revenues Rs m33,04031,77129,28732,33233,254 
Gross profit Rs m7,3835,3632,8964,3814,505 
Depreciation Rs m1,0311,7961,6331,7301,777 
Interest Rs m269284319241240 
Profit before tax Rs m6,3063,6111,1662,6212,905 
Minority Interest Rs m00000 
Prior Period Items Rs m3-49000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,5241,019204675511 
Profit after tax Rs m4,7852,5429621,9452,394 
Gross profit margin %22.517.110.013.613.7 
Effective tax rate %24.228.217.525.817.6 
Net profit margin %14.68.13.36.17.3 
IPCA LABS BALANCE SHEET DATA
Current assets Rs m16,01419,34816,21917,41819,455 
Current liabilities Rs m7,91512,5179,7009,55910,076 
Net working cap to sales %24.721.722.424.528.6 
Current ratio x2.01.51.71.81.9 
Inventory Days Days9410710510098 
Debtors Days Days5073565767 
Net fixed assets Rs m14,84120,54021,42920,77920,260 
Share capital Rs m252252252252252 
"Free" reserves Rs m19,09821,56422,57824,30026,633 
Net worth Rs m19,59721,96522,59224,55326,886 
Long term debt Rs m2,9404,9874,8433,5172,340 
Total assets Rs m32,10641,24838,91739,59541,173 
Interest coverage x24.513.74.711.913.1 
Debt to equity ratio x0.20.20.20.10.1 
Sales to assets ratio x1.00.80.70.80.8 
Return on assets %15.76.93.35.56.4 
Return on equity %24.411.64.37.98.9 
Return on capital %29.214.35.410.210.8 
Exports to sales %60.452.949.248.647.6 
Imports to sales %16.116.715.314.214.9 
Exports (fob) Rs m19,83616,62414,29915,61715,642 
Imports (cif) Rs m5,2825,2474,4454,5714,884 
Fx inflow Rs m20,04816,74914,29915,61715,642 
Fx outflow Rs m7,2726,9565,8224,5714,884 
Net fx Rs m12,7769,7938,47711,04610,759 
IPCA LABS CASH FLOW
From Operations Rs m 5,223 4,682 7,087 2,819 3,411 
From Investments Rs m -3,690 -6,893 -2,183 -1,488 -1,354 
From Financial Activity Rs m -1,361 2,505 -4,615 -1,591 -1,304 
Net Cashflow Rs m 172 294 288 -260 753 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 45.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 11.4%
FIIs 25.3%
ADR/GDR 0.0%
Free float 17.4%
Shareholders 36,892
Pledged promoter(s) holding 2.1%
 

Company Information

REGD OFF 48, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067
E-MAIL investors@ipca.com WEB www.ipca.com
TELEPHONE (022) 6647 4444 FAX (022) 2868 6613
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Natvarlal Vepari & Co.
CHM: Premchand Godha (MD) COMP SEC: Harish P. Kamath (VP - Legal) YEAR OF INC: 1949 BSE CODE: 524494 FV (Rs): 2 DIV YIELD (%): 0.1

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA  PLETHICO PHARMA  J.B.CHEMICALS  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare IPCA LABS With:   SUN PHARMA  PLETHICO PHARMA  J.B.CHEMICALS  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare IPCA LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Sensex Ends 268 Points Higher(Closing)

After opening the day marginally higher, Indian share markets continued their momentum and ended their day on a positive note.

Views on news

IPCA LABS Announces Quarterly Results (3QFY19); Net Profit Up 51.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY19); Net Profit Up 24.1% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, IPCA LABS has posted a net profit of Rs 1 bn (up 24.1% YoY). Sales on the other hand came in at Rs 10 bn (up 15.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - ACTAVIS COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS